2021 American Transplant Congress
Cytomegalovirus (CMV) D+/R- Serostatus is Independently Associated with Mortality and Graft Loss After Liver Transplantation (LTx)
Internal Medicine, University of Washington Medical Center, Seattle, WA
*Purpose: It is unknown if donor or recipient (D/R) CMV serostatus, in the era of CMV prophylactic and pre-emptive strategies, remains associated with clinical outcomes…2021 American Transplant Congress
Outcomes of HLA Antibody Surveillance Protocol in Heart Transplant Patients – A Single-Center Retrospective Analysis
Baylor University Medical Center, Dallas, TX
*Purpose: Post-transplant care is multifaceted with protocols to provide oversight and maintain the standard of care. While institutional protocols for post-transplant HLA antibody surveillance after…2021 American Transplant Congress
Impact of Social Support, Social Circumstances and Distance from Transplant Center on Post Liver Transplant Outcomes: An Analysis from a Predominantly Rural U.S. Cohort
1University of Arkansas for Medical Sciences, Little Rock, AR, 2Henry Ford Hospital, Detroit, MI
*Purpose: Social support and social circumstances (SSSC) are critical yet less described entities in post-orthotopic liver transplant (OLT). We aimed to describe SSSC and correlate…2021 American Transplant Congress
Postoperative Tracheostomy as a Predictor of Poor Clinical Outcomes in Lung Transplantation
Indiana University School of Medicine, Indianapolis, IN
*Purpose: Tracheostomies are commonly performed postoperatively in lung transplant recipients to provide ventilation for prolonged periods, and with relatively few studies detailing these patients’ outcomes…2021 American Transplant Congress
Do Pretransplant C-peptide Levels Influence Outcomes in Simultaneous Pancreas-Kidney Transplantation? A Matched Case-Control Study
Abdominal Transplant Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC
*Purpose: Experience with simultaneous pancreas-kidney transplant (SPKT) in uremic patients (pts) with detectable pretransplant C-peptide (Cp) levels and a “type 2” diabetes mellitus (DM) phenotype…2021 American Transplant Congress
Pre-Transplant Frailty is Associated with 30-Day Mortality but Not Long-Term Survival After Liver Transplantation
Department of Surgery, University of Michigan Health System, Ann Arbor, MI
*Purpose: Frailty predicts waitlist death in liver transplant (LT) candidates, but the impact of frailty on mortality after LT is unknown. We investigated the association…2021 American Transplant Congress
COVID-19 in Kidney Transplant Recipients in the Southeastern United States: A Single Center Experience
Vanderbilt University Medical Center, Nashville, TN
*Purpose: The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19, has emerged as a viral pandemic and brought unprecedented challenges worldwide on…2021 American Transplant Congress
The Combined Effects of Simultaneous Portal Vein Thrombosis and Renal Dysfunction in Liver Transplant Recipients
*Purpose: Simultaneous portal vein thrombosis (PVT) and renal dysfunction (RD) have unknown effects after liver transplant (LT). We analyzed the outcomes of patients with simultaneous…2021 American Transplant Congress
Pathology of the Explanted Lungs and Surveillance Allograft Biopsy in 202 Lung Transplant Cases: Single Institution Experience
*Purpose: This study correlates lung transplantation outcomes with pathologic diagnoses of explants and surveillance transbronchial allograft biopsies.*Methods: A retrospective IRB approved review of archival material…2021 American Transplant Congress
Increasing Survival on the Kidney Transplant Waiting List: A Thirty-Three Year Analysis
*Purpose: The shortage of available donor kidneys remains the greatest obstacle to transplantation, with many patients spending years on the transplant list. During this time,…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 66
- Next Page »